An observational study in Surgery, sponsored by National Cancer Centre, Singapore. Completed at 2 sites in Singapore. Open to participants aged 21 Years to 100 Years. Per ClinicalTrials.gov, last updated 2021-07-14.
Sponsored by National Cancer Centre, Singapore · Observational
This study aims to look at the impact on patient outcomes arising from measures implemented during the COVID-19 pandemic. The information and knowledge from this study will be useful for the management and allocation of hospital resources and patients in tne event of a disease outbreak.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 11,000 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →National Cancer Centre, Singapore is the lead sponsor of 116 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This study seeks to assess the effect of the measures taken to contain COVID 19 on patients who need surgical services measured by patient outcomes, such as, length of hospital stay (LOS), ICU stay, APACHE score, and stage of cancer at surgery.
From the identified surgical procedure type or the following cancer-related procedures:
Selected non-cancer surgeries:
Exclusion Criteria:
Analysis of patients according to type of surgical procedures, medical condition and dates of surgical treatment retrospectively.
These patients are classified according to the institution, type of surgical procedures, the medical condition and the dates of surgical treatment. The study will be compared across four time periods.
Time frame: 1 Jan - 31 Dec 2017, 1 Jan - 31 Dec 2018, 1 Jan - 31 Dec 2019, 1 Jan - 31 Dec 2020
Comparing surgical indices for high volume cancer and non-cancer diagnoses
The study focus on surgical indices for selected high-volume cancer and non-cancer diagnoses over the period 1st January2020 to 31 December 2020 and compare them with similar indices across the same period of time in the preceding 3 years in particular, for the following surgical procedures: 1. Surgeries for the following cancer diagnoses: 1. breast cancer, \[XIV- N60, no malignancy\], \[Malignant, IINeoplasms- C50\], colorectal cancer, \[C18, 19, 20\], 2. hepatocellular carcinoma, \[C22\] 2. Selected non-cancer surgeries: 1. Cholecystectomy 2. Abdominal hernia repair
Time frame: 1 Jan 2020 - 31 Dec 2020
Plan to share: No
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Centre, Singapore